Talking Ketamine Podcast

About Talking Ketamine Podcast

Explore the cutting-edge science and therapeutic potential of ketamine. Talking Ketamine offers evidence-based discussions to demystify its role in mental health and beyond, providing informed insights into this powerful compound. Each episode explores a recent scientific study that explores an interesting aspect of ketamine treatment, ketamine therapy, and ketamine use in mental health. The podcast has covered topics ranging from ketamine and music to ketamine's surprising help in battling some cancers. Most of the papers covered are cutting edge science so you may not want to make medical decisions from them. But, each piece of evidence, good or bad, big or small, guides us to a better understanding of this miraculous medicine. If you are interested in ketamine research because you suffer from MDD or are having thoughts of suicide, please dial 988 or visit https://988lifeline.org (https://988lifeline.org) in the US or go to https://findahelpline.com/ (https://findahelpline.com/) to find help in your location.

Publisher

Talking Ketamine

Category

health & fitness

Language

en

Explicit

No

First episode

19 Nov 2024

Latest episode

3 Oct 2026

Latest episodes

87 episodes in the feed.

1. 

   3 Oct 2026

   Bridging the Antidepressant Gap

   The most dangerous window in severe depression occurs during the four to eight week lag before conventional antidepressants take effect, a vulnerable period where suicide risk peaks. A breakthrough randomized controlled trial demonstrates that frontline add-on intravenous ketamine completely eliminates this agonizing delay, delivering meaningful clinical relief within 48 hours. Discover how just four infusions achieved a 58% response rate, cleared suicidal ideation to absolute zero within five days, and sustained recovery at four weeks. We also unpack the vital anxiety paradox that dictates who should, and who should not, receive this rapid intervention. Tune in to explore how emergency psychiatry can shift from passive observation into proactive, rapid neuroplastic healing. Resources: Prakash, A., Mahapatra, P., Pattnaik, J. I., Panda, U. K., & Das, S. K. (2026). Add-on intravenous ketamine eliminates treatment lag period in severe non-treatment-resistant major depression: Rapid antidepressant and anti-suicidal effects – A randomized controlled trial. *Indian Journal of Psychiatry*, *68*(9), 776–783. https://doi.org/10.4103/indianjpsychiatry_845_25

2. 

   28 Sept 2026

   The Brain's Chemical Seesaw

   ## 🎧 Episode 82: The Brain's Chemical Seesaw ### Enticing One-Sentence Description What if ketamine doesn't relieve depression by permanently altering brain chemicals, but by forcing a stuck neural seesaw to recalibrate in real time? We dive into a landmark meta-analysis of living brain imaging studies to reveal why lasting relief is rooted in a dynamic balancing act mid-infusion—and how individual baseline chemistry could finally eliminate psychiatric guesswork. ### Engaging Description For decades, depression was blamed on a chemical deficit, but what if brain imaging has been taking snapshots at the wrong times? A landmark systematic review reveals that ketamine leaves 24-hour resting neurotransmitter levels unchanged—because its true antidepressant power is a dynamic balancing act unfolding mid-infusion. Discover how acute glutamate cycling disrupts rigid neural ruts to reset the excitation-inhibition balance, and why baseline Glx/GABA ratios in the anterior cingulate cortex predict clinical remission. We unpack how these real-time neurochemical shifts validate the patient experience and open doors for precision psychiatry. Tune in to explore why ketamine tunes the brain rather than applying a blunt chemical fix. Resources: Singh, B., Ali, H. M., Miola, A., Nunez, N. A., Fogaça, M. V., Jelen, L. A., Prokop, L. J., Sanacora, G., Zarate, C. A., Jr., Frye, M. A., & Port, J. D. (2026). Modulation of GABA and glutamate by ketamine in depression: A systematic review and meta-analysis of magnetic resonance spectroscopy studies. *Neuropsychopharmacology*. Advance online publication. https://doi.org/10.1038/s41386-026-02562-4 ### Categories - Clinical Applications - Ketamine Therapy - Neuroscience & Brain Function ### Tags Antidepressant Effects, Biomarkers, Brain Changes, Clinical Applications, Depression, Glutamate, Human Trials, Infusion Therapy, Ketamine, Ketamine Therapy, Mental Health, Neuroplasticity, Neuroscience & Brain Function, Systematic Review, Treatment-Resistant Depression (TRD) ### Bluesky Post Does ketamine just boost brain chemicals? 🧪 Ep 82 explores new research showing ketamine rebalances neural circuits mid-infusion. ⚖️ Dynamic glutamate-GABA reset 🎯 Baseline chemistry predicts relief 🎧 [Link] #Ketamine #Neuroscience #MentalHealth ### Video Stream [Watch Video Stream](https://customer-e74b32de40b3ccf4220e6a9a542fa8e5.cloudflarestream.com/984625bc1447c58e7bd239a1d537454e/manifest/video.m3u8)

3. 

   22 Sept 2026

   Does Ketamine Damage the Brain?

   Sensational headlines warn that ketamine shrinks brain tissue, but what actually happens to human neuroanatomy under chronic, extreme exposure? A landmark systematic review analyzing brain scans from hundreds of heavy recreational users reveals exactly where therapeutic healing ends and structural degradation begins. Discover how years of multi-gram daily abuse erode cortical gray matter and fray white matter wiring through glutamate excitotoxicity, while low-dose medical treatments protect and rebuild neural networks. We unpack critical research caveats like polydrug use and reveal why the dose truly makes the poison. Tune in to separate internet panic from clinical reality and protect your peace of mind. Resources: Strous, J. F. M., Weeland, C. J., van der Draai, F. A., Daams, J. G., Denys, D., Lok, A., Schoevers, R. A., & Figee, M. (2022). Brain changes associated with long-term ketamine abuse, a systematic review. Frontiers in Neuroanatomy, 16, Article 795231. https://doi.org/10.3389/fnana.2022.795231 (https://doi.org/10.3389/fnana.2022.795231)

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

YouTube views

264

Score snapshot 15 Sept 2025

Apple Podcasts (US)

3.9 / 5

14 ratings

Spotify

1.0 / 5

2 ratings

Podcast Authority Score: 45 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

53

Social presence

0

YouTube

64

Engagement

31

Contact Talking Ketamine Podcast

Guest appearances

Does not typically book guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Shows with a similar audience

• 

  Ketamine Connections

• 

  Ketamine Insights

• 

  RECOVERable: Mental Health and Addiction Experts Answer Your Questions

• 

  The Psychedelic Podcast

• 

  Hidden Brain

• 

  Huberman Lab

Questions about Talking Ketamine Podcast